AU3163795A - Treatment of autoimmune diseases - Google Patents

Treatment of autoimmune diseases

Info

Publication number
AU3163795A
AU3163795A AU31637/95A AU3163795A AU3163795A AU 3163795 A AU3163795 A AU 3163795A AU 31637/95 A AU31637/95 A AU 31637/95A AU 3163795 A AU3163795 A AU 3163795A AU 3163795 A AU3163795 A AU 3163795A
Authority
AU
Australia
Prior art keywords
treatment
autoimmune diseases
autoimmune
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31637/95A
Inventor
Erna Moller
Cecilia Soderberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3163795A publication Critical patent/AU3163795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU31637/95A 1994-07-20 1995-07-20 Treatment of autoimmune diseases Abandoned AU3163795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9414652A GB9414652D0 (en) 1994-07-20 1994-07-20 Method of treatment
GB9414652 1994-07-20
PCT/EP1995/002885 WO1996002272A2 (en) 1994-07-20 1995-07-20 Treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
AU3163795A true AU3163795A (en) 1996-02-16

Family

ID=10758627

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31637/95A Abandoned AU3163795A (en) 1994-07-20 1995-07-20 Treatment of autoimmune diseases

Country Status (4)

Country Link
EP (1) EP0773793A1 (en)
AU (1) AU3163795A (en)
GB (1) GB9414652D0 (en)
WO (1) WO1996002272A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10934209B2 (en) 2016-10-13 2021-03-02 Corning Incorporated Glass-based articles having improved fracture performance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03504079A (en) * 1988-03-21 1991-09-12 カイロン　コーポレイション recombinant retrovirus
US5252603A (en) * 1989-03-15 1993-10-12 Cetus Corporation Immunosuppressive analogues and derivatives of succinylacetone
US5147289A (en) * 1990-03-29 1992-09-15 Therakos, Inc Non-specific immune system enhancement

Also Published As

Publication number Publication date
EP0773793A1 (en) 1997-05-21
WO1996002272A3 (en) 1996-03-21
GB9414652D0 (en) 1994-09-07
WO1996002272A2 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
AU7905894A (en) Treatment of poultry
AU7867994A (en) Hemofiltration of mediator-related diseases
AU4582797A (en) Methods for treatment of retinal diseases
AU7250294A (en) Treatment of multidrug resistant diseases
AU7772794A (en) Treatment of obesity
AUPM761094A0 (en) Treatment of hides
AU8153794A (en) Methods of inhibiting autoimmune diseases
AU2972497A (en) Treatment of oils
AU6328696A (en) Treatment of hemoglobinopathies
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
AU2749395A (en) Medical use of bromelain
AU3552697A (en) Novel treatment of leptine resistance
AU4224096A (en) Use of phenylcyclohexylcarboxamides
HUP9802834A3 (en) Preparations for the treatment of t cell mediated autoimmune diseases
ZA971607B (en) Methods of treatment of allergic diseases
AU5340594A (en) Skin treatment
AU4546096A (en) Treatment of waste
AU6829696A (en) Treatment of solutions
AU1181897A (en) Medical use of proteases
AU8185491A (en) Treatment of disease
AU2754997A (en) The treatment of plant diseases
AU3163795A (en) Treatment of autoimmune diseases
AU6171196A (en) Therapeutic uses of ta99
AU1931895A (en) Treatment of graft-versus-host disease
AU7695891A (en) Treatment of autoimmune diseases